Back to Agenda
Consideration for the Safety of Clinical Research & Development Plan
Session Chair(s)
Yuan Meng
Head of Medical Office R&D
I-Mab Biopharma , China
Consideration for the Safety of Clinical Research & Development Plan
Have an account?